BridgeMD
New treatment option for Kidney Failure,Chronic
Official title Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
ClinicalTrials.gov ID: NCT06917950
What this study is testing
What is Roxadustat?
Roxadustat is an investigational medicine, given as a monthly pill taken by mouth, being studied as a potential treatment for kidney failure,chronic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- People with severe kidney failure who need regular hemodialysis treatment often experience several health problems. These include anemia (low red blood cell count), issues with their bone health (sometimes called mineral and bone disease), and mental health challenges like depression and anxiety.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 3 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The age of the patient is more than 18.
- Patients who are willing to sign informed consent.
- Patients with ESKD on chronic hemodialysis for more than 3 months.
You likely can't join if
- Current pregnancy or lactation.
- Patients with pre-existing malignancy.
- patients with psychosis.
- Known history of hematological disorders or other causes of anemia other than CKD.
- Taking medications that may significantly affect or interact with bone metabolism such as osteo-anabolics or bone resorptives during the last 6...
The study team makes the final eligibility decision.
Where it's taking place
- Al Mansurah, Dakahliya, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Al Mansurah, Dakahliya, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.